Description

Tarazepide is a synthetic chemical compound with significant utility in advanced pharmaceutical research and development. Its primary value lies in its role as a key intermediate or active pharmaceutical ingredient (API) in the synthesis of novel therapeutic agents. This product is essential for research institutions and pharmaceutical manufacturers focused on developing new drug candidates, particularly in metabolic and neurological research areas. We supply high-purity Tarazepide CAS NO 141374-81-4 to support innovation and ensure reliable outcomes in critical applications.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the multi-step synthesis of proprietary drug candidates.
• Active Pharmaceutical Ingredient (API) Research: Used in preclinical and clinical research for developing new therapeutic formulations.
• Metabolic Disorder Research: Investigated in studies related to appetite regulation, weight management, and metabolic pathways.
• Neurological & Behavioral Research: Applied in research models studying central nervous system (CNS) targets and related disorders.
• Reference Standard: Employed as an analytical standard in quality control laboratories for method development and validation.
• Process Chemistry & Scale-Up: Utilized in process optimization and pilot-scale manufacturing for new chemical entities (NCEs).

Basic Information

Product Name	Tarazepide
CAS No.	141374-81-4
Molecular Formula	C23H28N4O3S
Molecular Weight	440.56 g/mol
Synonyms	Tarazepide; 141374-81-4; 1,2,3,4-Tetrahydro-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]pyrido[1,2-a]pyrimidin-4-one; CCK-A receptor antagonist; L-364,718; Devazepide; MK-329; CR 1505; (3S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide (Note: Some synonyms may refer to closely related analogs; confirm structure for specific grade).
EINECS	Contact for details

Quality Control

Our Tarazepide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity, identity confirmation by IR and NMR, and residual solvent analysis, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) is provided with every shipment, detailing all specification results. We adhere to cGMP principles where applicable to guarantee consistency, traceability, and reliability for our global B2B clients.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider using desiccants.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single unknown impurity ≤ 0.5%
Residual Solvents (GC)	Complies with ICH Q3C guidelines
Loss on Drying	≤ 1.0%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.